サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Transdermal Drug Delivery System Market- Global Forecast to 2023

経皮吸収型ドラッグデリバリーシステムー2023年までの世界予測

レポート概要

経皮吸収型ドラッグデリバリーシステム市場、種類別(パッチ、半固形製剤)、用途別(疼痛管理、中枢神経系疾患、ホルモン療法、心血管疾患)、エンドユーザー別、地域別‐2023年までの世界予測

経皮吸収型ドラッグデリバリーシステム市場は2018年に57億ドル、2023年までに71億ドルに達すると予想されます。この市場の主な推進要因は、慢性疾患の罹患率の上昇や経皮吸収型ドラッグデリバリーシステムにおける技術の進歩です。

用途別では疼痛管理のセグメントが最大のシェアを占めるでしょう。

この市場は用途別に5つのセグメント、即ち疼痛管理、中枢神経系疾患、ホルモン療法、心血管疾患、その他の用途(禁煙、乗り物酔い、過活動膀胱の治療)に分類されます。

予測期間中、経皮吸収パッチが経皮吸収型ドラッグデリバリーシステム市場の大半を占めるでしょう。

種類別に見ると、経皮吸収型ドラッグデリバリーシステム市場は経皮吸収パッチと経皮吸収半固形製剤に分類されます。予測期間中、経皮吸収パッチは増加率も上昇する見込みです。

予測期間中は在宅医療のセグメントが最大の伸び率となる見込みです。経皮吸収型ドラッグデリバリーシステム市場はエンドユーザー別に在宅医療と病院&クリニックに分類されます。この期間中、在宅医療セグメントのCAGRは上昇する見込みです。その要因としては、在宅における自己投与の増加、世界的に急速な高齢化、費用対効果の高い薬剤投与法に対するニーズの高まりがあります。

レポート詳細

目次

Table of Contents

1 Introduction (Page No. - 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. - 18)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Market Data Validation and Triangulation
2.3 Assumptions for the Study

3 Executive Summary (Page No. - 28)

4 Premium Insights (Page No. - 32)
4.1 Transdermal Drug Delivery Systems Market Overview
4.2 Transdermal Drug Delivery Systems Market, By Type, 2018
4.3 Transdermal Drug Delivery Systems Market, By Type, 2018
4.4 Transdermal Drug Delivery Systems Market: Geographic Snapshot

5 Market Overview (Page No. - 36)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Prevalence of Chronic Diseases
5.2.1.2 Technological Advancements in Transdermal Drug Delivery Systems
5.2.2 Restraints
5.2.2.1 Drug Failure and Recalls of Transdermal Drug Delivery Systems
5.2.3 Opportunities
5.2.3.1 Collaborations Between Pharmaceutical Companies and Drug Delivery Firms
5.2.3.2 Self-Administration and Home Care Drug Delivery Systems
5.2.4 Challenges
5.2.4.1 Technical Barriers Related to Skin Irritation and Permeability

6 Transdermal Drug Delivery Systems Market, By Type (Page No. - 40)
6.1 Introduction
6.2 Transdermal Patches
6.2.1 Drug-In-Adhesive Patches
6.2.2 Matrix Patches
6.2.3 Reservoir Membrane Patches
6.2.4 Microneedle Patches
6.3 Transdermal Semisolids
6.3.1 Gels
6.3.2 Ointments
6.3.3 Sprays

7 Transdermal Drug Delivery Systems Market, By Application (Page No. - 47)
7.1 Introduction
7.2 Pain Management
7.2.1 Pain Management to Account for the Largest Share of the Transdermal Drug Delivery Systems Market
7.3 Hormonal Applications
7.3.1 Testosterone Replacement Therapy
7.3.1.1 Skin Irritation, Poor Absorption of Drugs, High Costs, and the Need for Frequent Dosing are Factors Limiting Market Growth
7.3.2 Transdermal Estrogen Therapy
7.3.2.1 Growing Use of Transdermal Contraceptive Patches is Likely to Drive the Market for Transdermal Estrogen Therapy
7.4 Central Nervous System Disorders
7.4.1 Increasing Incidence of Parkinson’s and Alzheimer’s Disease to Drive the Market for Central Nervous System Disorders
7.5 Cardiovascular Diseases
7.5.1 Availability of Alternative and Advanced Drug Delivery Options to Limit Market Growth
7.6 Other Applications
7.6.1 Increasing Demand for Advanced Transdermal Microneedle Patches for Diabetes Management—A Key Market Driver

8 Transdermal Drug Delivery Systems Market, By End User (Page No. - 59)
8.1 Introduction
8.2 Home Care Settings
8.3 Hospitals & Clinics

9 Transdermal Drug Delivery Systems Market, By Region (Page No. - 64)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 Rising Prevalence of Targeted Disease and Development of Technologically Advanced Transdermal Drug Delivery Systems—Key Factors Driving Market Growth
9.2.2 Canada
9.2.2.1 Rising Prevalence of Chronic Diseases and Funding for the Development of Transdermal Drug Delivery Systems to Drive Market Growth
9.3 Europe
9.3.1 Germany
9.3.1.1 Growing Focus of Pharmaceutical Companies in Germany on the Development of Transdermal Products to Drive Market Growth
9.3.2 UK
9.3.2.1 Increasing Funding for the R&D of Innovative Transdermal Technologies to Drive Market Growth
9.3.3 France
9.3.3.1 Development of Transdermal Drug Delivery Systems By Local Players to Support Market Growth
9.3.4 RoE
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Increasing Number of Product Approvals and Growing Focus of Local Players on R&D of Transdermal Systems to Support Market Growth
9.4.2 China
9.4.2.1 Growing Focus of Major Players in China Towards the Development of Transdermal Drug Delivery Systems to Drive Market Growth
9.4.3 India
9.4.3.1 Growing Awareness Among Healthcare Providers and Patients and Increasing Focus on Noninvasive Methods of Drug Delivery to Drive Market Growth
9.4.4 Ropac
9.5 RoW

10 Competitive Landscape (Page No. - 99)
10.1 Overview
10.2 Market Share Analysis
10.3 Market Share Analysis, By Application
10.3.1 Pain Management
10.3.2 Hormonal Applications
10.3.3 Central Nervous System Disorders
10.3.4 Cardiovascular Diseases
10.4 Competitive Scenario
10.4.1 Product Launches and Approvals
10.4.2 Expansions
10.4.3 Agreements and Collaborations
10.4.4 Acquisitions

11 Company Profiles (Page No. - 105)
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 Hisamitsu Pharmaceutical Co., Inc.
11.2 Mylan N.V.
11.3 UCB S.A.
11.4 Novartis AG
11.5 Glaxosmithkline PLC
11.6 Boehringer Ingelheim International GmbH
11.7 Johnson & Johnson (J&J)
11.8 Endo International, Inc.
11.9 Purdue Pharma L.P.
11.10 Lavipharm
11.11 Lead Chemicals Co., Inc.
11.12 Luye Pharma Group

*Details on Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 127)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details

List of Tables (71 Tables)
Table 1 Comparison Between Transdermal Patches and Transdermal Semisolid Formulations
Table 2 Transdermal Drug Delivery Systems Market, By Type, 2016-2023 (USD Million)
Table 3 Transdermal Patches Market, By Type, 2016-2023 (USD Million)
Table 4 Transdermal Patches Market, By Country, 2016-2023 (USD Million)
Table 5 Transdermal Semisolids Market, By Country, 2016-2023 (USD Million)
Table 6 Transdermal Drug Delivery Systems Market, By Application, 2016-2023 (USD Million)
Table 7 Transdermal Drug Delivery Systems Available for Pain Management
Table 8 Transdermal Drug Delivery Systems Market for Pain Management, By Country, 2016-2023 (USD Million)
Table 9 Market for Hormonal Applications, By Country, 2016-2023 (USD Million)
Table 10 Market for Hormonal Applications, By Type, 2016-2023 (USD Million)
Table 11 Transdermal Drug Delivery Systems Available for Testosterone Replacement Therapy
Table 12 Transdermal Drug Delivery Systems Available for Transdermal Estrogen Therapy
Table 13 Transdermal Drug Delivery Systems Available for Central Nervous System Disorders
Table 14 Market for Central Nervous System Disorders, By Country, 2016-2023 (USD Million)
Table 15 Transdermal Drug Delivery Systems Available for Cardiovascular Diseases
Table 16 Market for Cardiovascular Diseases, By Country, 2016-2023 (USD Million)
Table 17 Transdermal Drug Delivery Systems Available for Other Applications
Table 18 Market for Other Applications, By Country, 2016-2023 (USD Million)
Table 19 Market, By End User, 2016-2023 (USD Million)
Table 20 Market for Home Care Settings, By Country, 2016-2023 (USD Million)
Table 21 Transdermal Drug Delivery Systems Market for Hospitals & Clinics, By Country, 2016-2023 (USD Million)
Table 22 Market, By Region, 2016-2023 (USD Million)
Table 23 North America: Transdermal Drug Delivery Systems Market, By Country, 2016-2023 (USD Million)
Table 24 North America: Market, By Application, 2016-2023 (USD Million)
Table 25 North America: Market, By Type, 2016-2023 (USD Million)
Table 26 North America: Market, By End User, 2016-2023 (USD Million)
Table 27 US: Transdermal Drug Delivery Systems Market, By Application, 2016-2023 (USD Million)
Table 28 US: Market, By Type, 2016-2023 (USD Million)
Table 29 US: Market, By End User, 2016-2023 (USD Million)
Table 30 Canada: Transdermal Drug Delivery Systems Market, By Application, 2016-2023 (USD Million)
Table 31 Canada: Market, By Type, 2016-2023 (USD Million)
Table 32 Canada: Market, By End User, 2016-2023 (USD Million)
Table 33 Developments in the Field of Tdds in Europe, 2015-2018
Table 34 Europe: Transdermal Drug Delivery Systems Market, By Country, 2016-2023 (USD Million)
Table 35 Europe: Market, By Application, 2016-2023 (USD Million)
Table 36 Europe: Market, By Type, 2016-2023 (USD Million)
Table 37 Europe: Market, By End User, 2016-2023 (USD Million)
Table 38 Germany: Transdermal Drug Delivery Systems Market, By Application, 2016-2023 (USD Million)
Table 39 Germany: Market, By Type, 2016-2023 (USD Million)
Table 40 Germany: Market, By End User, 2016-2023 (USD Million)
Table 41 UK: Transdermal Drug Delivery Systems Market, By Application, 2016-2023 (USD Million)
Table 42 UK: Market, By Type, 2016-2023 (USD Million)
Table 43 UK: Market, By End User, 2016-2023 (USD Million)
Table 44 France: Transdermal Drug Delivery Systems Market, By Application, 2016-2023 (USD Million)
Table 45 France: Market, By Type, 2016-2023 (USD Million)
Table 46 France: Market, By End User, 2016-2023 (USD Million)
Table 47 RoE: Transdermal Drug Delivery Systems Market, By Application, 2016-2023 (USD Million)
Table 48 RoE: Market, By Type, 2016-2023 (USD Million)
Table 49 RoE: Market, By End User, 2016-2023 (USD Million)
Table 50 Asia Pacific: Transdermal Drug Delivery Systems Market, By Country, 2016-2023 (USD Million)
Table 51 Asia Pacific: Market, By Application, 2016-2023 (USD Million)
Table 52 Asia Pacific: Market, By Type, 2016-2023 (USD Million)
Table 53 Asia Pacific: Market, By End User, 2016-2023 (USD Million)
Table 54 Japan: Transdermal Drug Delivery Systems Market, By Application, 2016-2023 (USD Million)
Table 55 Japan: Market, By Type, 2016-2023 (USD Million)
Table 56 Japan: Market, By End User, 2016-2023 (USD Million)
Table 57 China: Transdermal Drug Delivery Systems Market, By Application, 2016-2023 (USD Million)
Table 58 China: Market, By Type, 2016-2023 (USD Million)
Table 59 China: Market, By End User, 2016-2023 (USD Million)
Table 60 India: Transdermal Drug Delivery Systems Market, By Application, 2016-2023 (USD Million)
Table 61 India: Market, By Type, 2016-2023 (USD Million)
Table 62 India: Market, By End User, 2016-2023 (USD Million)
Table 63 RoAPAC: Market, By Application, 2016-2023 (USD Million)
Table 64 RoAPAC: Market, By Type, 2016-2023 (USD Million)
Table 65 RoAPAC: Market, By End User, 2016-2023 (USD Million)
Table 66 RoW: Market, By Application, 2016-2023 (USD Million)
Table 67 RoW: Market, By Type, 2016-2023 (USD Million)
Table 68 RoW: Market, By End User, 2016-2023 (USD Million)
Table 69 Product Launches and Approvals
Table 70 Expansions
Table 71 Agreements and Collaborations

List of Figures (35 Figures)
Figure 1 Transdermal Drug Delivery Systems Market Segmentation
Figure 2 Transdermal Drug Delivery Systems Market: Research Methodology
Figure 3 Research Design
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Transdermal Drug Delivery Systems Market, By Type, 2018
Figure 9 Transdermal Drug Delivery Systems Market, By Application, 2018
Figure 10 Transdermal Drug Delivery Systems Market, By End User, 2018
Figure 11 Geographic Snapshot: Transdermal Drug Delivery Systems Market
Figure 12 Increase in the Prevalence of Chronic Diseases and Technological Advancements are Key Factors Driving the Growth of the Market
Figure 13 Transdermal Patches to Dominate the Transdermal Drug Delivery Systems in North American Market During the Forecast Period
Figure 14 Transdermal Patches to Dominate the Transdermal Drug Delivery Systems in North European Market During the Forecast Period
Figure 15 Japan is Expected to Grow at the Highest CAGR During the Forecast Period
Figure 16 Market: Drivers, Restraints, Opportunities, & Challenges
Figure 17 Market, By Type, 2018 vs 2023 (USD Million)
Figure 18 Market, By Application, 2018 vs 2023 (USD Million)
Figure 19 Market, By End User, 2018 vs 2023 (USD Million)
Figure 20 Market, By Region, 2018 vs 2023
Figure 21 North America: Market Snapshot
Figure 22 Europe: Market Snapshot
Figure 23 Asia Pacific: Market Snapshot
Figure 24 RoW: Market Snapshot
Figure 25 Key Developments in the Transdermal Drug Delivery Systems Market (2015-2018)
Figure 26 Market Share Analysis By Key Players (2015-2018)
Figure 27 Hisamitsu Pharmaceutical: Company Snapshot (2017)
Figure 28 Mylan: Company Snapshot (2017)
Figure 29 UCB: Company Snapshot (2017)
Figure 30 Novartis: Company Snapshot (2017)
Figure 31 GSK: Company Snapshot (2017)
Figure 32 Boehringer Ingelheim: Company Snapshot (2017)
Figure 33 Johnson & Johnson: Company Snapshot (2017)
Figure 34 Endo International: Company Snapshot (2017)
Figure 35 Luye Pharma: Company Snapshot (2017)

発刊日

2019/01

体裁

PDF / 133ページ

販売価格

5,650USD

発行

MarketsandMarkets

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

医薬品原料・製剤 / 疾病別治療・領域別治療

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE